Plain-English translation of NCT02038127 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This trial is comparing three different drug-coated stents — Biomatrix, Xience, and Endeavor Resolute — to see which works best at keeping heart arteries open in patients with coronary artery disease. All three stents release medication slowly to prevent the artery from narrowing again after the procedure. The study will follow about 5,000 patients to understand which stent performs best over time.
When heart arteries become blocked, doctors use a procedure to insert a stent that holds the artery open and prevents it from closing again. This medication is designed to reduce the risk of the artery narrowing in the future, but researchers want to know which version of the treatment works best for the most patients.
You likely qualify if…
You likely don't qualify if…
You will receive one of the three stents during a catheterization procedure performed by your cardiologist. After the procedure, you will need to take blood-thinning medications as prescribed and attend follow-up visits so the research team can monitor how well your stent is working. The study will track your heart health and any symptoms over time, and you'll be part of a registry that helps doctors understand which stent works best for patients like you.
AI-generated summary from trial data · Aug 10, 2026 · Not medical advice
South Korea